Blurbs

Analysts Offer Insights on Healthcare Companies: Cigna (CI) and BioNano Genomics (BNGO)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Cigna (CIResearch Report) and BioNano Genomics (BNGOResearch Report) with bullish sentiments.

Cigna (CI)

BMO Capital analyst Matthew Borsch maintained a Buy rating on Cigna today and set a price target of $300.00. The company’s shares closed last Thursday at $217.56.

According to TipRanks.com, Borsch is a 3-star analyst with an average return of 5.3% and a 57.9% success rate. Borsch covers the Healthcare sector, focusing on stocks such as Aveanna Healthcare Holdings, Encompass Health, and HCA Healthcare.

Cigna has an analyst consensus of Moderate Buy, with a price target consensus of $260.77.

See today’s best-performing stocks on TipRanks >>

BioNano Genomics (BNGO)

Maxim Group analyst Jason McCarthy maintained a Buy rating on BioNano Genomics on February 2 and set a price target of $6.00. The company’s shares closed last Thursday at $2.06, close to its 52-week low of $1.81.

According to TipRanks.com, McCarthy ‘s ranking currently consits of 0 on a 0-5 ranking scale, with an average return of -22.0% and a 15.1% success rate. McCarthy covers the Healthcare sector, focusing on stocks such as Appili Therapeutics Inc Class A, Reviva Pharmaceuticals Holdings, and Brainstorm Cell Therapeutics.

Currently, the analyst consensus on BioNano Genomics is a Strong Buy with an average price target of $8.00.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on CI:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More
Videos
Videos

Latest News Feed